Back to Search Start Over

Phase I and pharmacokinetic study of <tex>Yondelis^{TM}$</tex> (ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

Authors :
Twelves, C.
Hoekman, K.
Bowman, A.
Vermorken, Jan Baptist
Anthoney, A.
Smyth, J.
van Kesteren, C.
Beijnen, J.H.
Uiters, J.
Wanders, J.
Gomez, J.
Guzmán, C.
Jimeno, J.
Hanauske, A.
EORTC, New Drug Development Group
Source :
European journal of cancer
Publication Year :
2003

Details

Language :
English
ISSN :
00142964
Database :
OpenAIRE
Journal :
European journal of cancer
Accession number :
edsair.od......2097..ce04a2a3f8083d0ecafa2ff6cbce2517

Tools

Authors Abstract Subjects Details